Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2020 | 2 |
2021 | 3 |
2022 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Moving towards Integrated and Personalized Care in Parkinson's Disease: A Framework Proposal for Training Parkinson Nurses.
J Pers Med. 2021 Jun 30;11(7):623. doi: 10.3390/jpm11070623.
J Pers Med. 2021.
PMID: 34209024
Free PMC article.
Review.
Evaluation of the Impact of Integrated Care and Self-Management After Deep Brain Stimulation in Parkinson's Disease.
Dash D, Cote D, Conway J, Grimes D, Mestre TA.
Dash D, et al. Among authors: cote d.
J Parkinsons Dis. 2022 Feb 28. doi: 10.3233/JPD-212911. Online ahead of print.
J Parkinsons Dis. 2022.
PMID: 35253775
Item in Clipboard
Pilot Evaluation of a Pragmatic Network for Integrated Care and Self-Management in Parkinson's Disease.
Mestre TA, Kessler D, Côté D, Liddy C, Thavorn K, Taljaard M, Grimes D.
Mestre TA, et al. Among authors: cote d.
Mov Disord. 2021 Feb;36(2):398-406. doi: 10.1002/mds.28332. Epub 2020 Oct 14.
Mov Disord. 2021.
PMID: 33280165
Item in Clipboard
The Integrated Parkinson's disease Care Network (IPCN): Qualitative evaluation of a new approach to care for Parkinson's disease.
Kessler D, Hatch S, Alexander L, Grimes D, Côté D, Liddy C, Mestre T.
Kessler D, et al. Among authors: cote d.
Patient Educ Couns. 2021 Jan;104(1):136-142. doi: 10.1016/j.pec.2020.07.002. Epub 2020 Jul 8.
Patient Educ Couns. 2021.
PMID: 32660740
Item in Clipboard
A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.
Parkinson Study Group QE3 Investigators; Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S…
See abstract for full author list ➔
Parkinson Study Group QE3 Investigators, et al. Among authors: cote d.
JAMA Neurol. 2014 May;71(5):543-52. doi: 10.1001/jamaneurol.2014.131.
JAMA Neurol. 2014.
PMID: 24664227
Clinical Trial.
Item in Clipboard
Cite
Cite